Stallergenes Greer announces publication of its 2016 annual report

April 28, 2017 – London (UK) - Stallergenes Greer (the “Company”) (Euronext Paris: STAGR), a biopharmaceutical company specialising in treatments for respiratory allergies, today announces the publication of its 2016 Annual Report.